News

Filter

Current filters:

Respiratory and Pulmonary

51 to 60 of 96094 results

AMBITION study of ambrisentan/tadalafil combo meets primary endpoint in PAH

AMBITION study of ambrisentan/tadalafil combo meets primary endpoint in PAH

08-09-2014

US biotech major Gilead Sciences today released results from the AMBITION study (a randomized, double-blind,…

Ambrisentan TabletsBiotechnologyGilead SciencesGlaxoSmithKlineInternational CongressOrganic chemistryResearchRespiratory and PulmonaryTadalafilUSA

China tops pharmaceutical material suppliers for Vietnam

China tops pharmaceutical material suppliers for Vietnam

08-09-2014

China is the largest supplier of pharmaceutical materials for Vietnam in the first seven months of 2014,…

AsiaAustriaBusiness FinanceChinaIndiaMarkets & MarketingPharmaceuticalVietnamXinhua

Meiji and Takeda to co-promote Rozerem for insomnia

Meiji and Takeda to co-promote Rozerem for insomnia

08-09-2014

Fellow Japanese drugmakers Meiji Seika Pharma and Takeda Pharmaceutical have finalized a co-promotion…

JapanLicensingMeiji Seika PharmaNeurologicalPharmaceuticalRozeremTakeda Pharmaceutical

GSK reports positive Phase III results of its mepolizumab in asthma

GSK reports positive Phase III results of its mepolizumab in asthma

08-09-2014

UK pharma major GlaxoSmithKline has reported positive data from its Phase III asthma studies of mepolizumab,…

GlaxoSmithKlineGSKImmunosuppressantsmepolizumabMepolizumabPharmaceuticalResearchRespiratory and PulmonaryUK

Mundipharma reports positive Ph III results for flutiform in pediatric asthma

08-09-2014

UK inhalation drug delivery specialist Skyepharma today announced that data from a randomized, multicenter,…

FlutiformGermanyMundipharmaPharmaceuticalPulmonologyResearchRespiratory and PulmonaryRespiratory therapySkyepharmaUK

51 to 60 of 96094 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top